MOMIGNIES PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MOMIGNIES PHARMA
Largest movements
- Receivables within one year -€117,877
down €117,877 (-36.0%), from €327,094 to €209,217
of which Other amounts receivable: -€128,319
- Tangible fixed assets +€115,415
up €115,415 (+121%), from €95,603 to €211,018
of which Plant, machinery and equipment: +€134,844
- Cash -€78,232
down €78,232 (-20.5%), from €381,017 to €302,785
mainly Investment in fixed assets (net) (-€141,814) and Other debts (-€74,675)
- Intangible fixed assets -€19,770
down €19,770 (-16.9%), from €116,969 to €97,199
- Stocks and contracts -€17,910
down €17,910 (-9.6%), from €187,479 to €169,570
- Other debts -€74,675
no longer reported in 2025 (was €74,675)
- Tax, wage and social debts -€36,413
down €36,413 (-57.5%), from €63,275 to €26,862
of which Taxes: -€49,126
- Trade debts -€24,532
down €24,532 (-16.3%), from €150,433 to €125,901
of which Bills of exchange payable: -€44,766
- Gross operating margin -€70,047
down €70,047 (-16.2%), from €433,491 to €363,444
- Taxes -€56,087
down €56,087 (-91.2%), from €61,468 to €5,381
- Staff costs +€49,479
up €49,479 (+37.9%), from €130,640 to €180,120
- Financial charges +€40,075
up €40,075 (+48.0%), from €83,470 to €123,545
- Depreciation +€20,129
up €20,129 (+77.3%), from €26,039 to €46,168
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,115,453 | €992,511 | -€122,943 | -11.0% |
| Fixed assets | 21/28 | €212,897 | €308,542 | +€95,645 | +44.9% |
| Intangible fixed assets | 21 | €116,969 | €97,199 | -€19,770 | -16.9% |
| Tangible fixed assets | 22/27 | €95,603 | €211,018 | +€115,415 | +121% |
| Plant, machinery and equipment | 23 | €1,885 | €136,729 | +€134,844 | +7,153% |
| Furniture and vehicles | 24 | €93,718 | €74,289 | -€19,429 | -20.7% |
| Financial fixed assets | 28 | €325 | €325 | = | 0.0% |
| Current assets | 29/58 | €902,556 | €683,968 | -€218,588 | -24.2% |
| Stocks and contracts in progress | 3 | €187,479 | €169,570 | -€17,910 | -9.6% |
| Stocks | 30/36 | €187,479 | €169,570 | -€17,910 | -9.6% |
| Amounts receivable within one year | 40/41 | €327,094 | €209,217 | -€117,877 | -36.0% |
| Trade receivables | 40 | €149,789 | €160,231 | +€10,442 | +7.0% |
| Other amounts receivable | 41 | €177,305 | €48,986 | -€128,319 | -72.4% |
| Cash at bank and in hand | 54/58 | €381,017 | €302,785 | -€78,232 | -20.5% |
| Deferred charges and accrued income | 490/1 | €6,966 | €2,397 | -€4,569 | -65.6% |
| Total equity and liabilities | 10/49 | €1,115,453 | €992,511 | -€122,943 | -11.0% |
| Equity | 10/15 | €822,355 | €829,869 | +€7,514 | +0.9% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €816,155 | €823,669 | +€7,514 | +0.9% |
| Distributable reserves | 133 | €816,155 | €823,669 | +€7,514 | +0.9% |
| Amounts payable | 17/49 | €293,098 | €162,641 | -€130,457 | -44.5% |
| Amounts payable within one year | 42/48 | €292,952 | €156,949 | -€136,003 | -46.4% |
| Current portion of amounts payable after more than one year | 42 | €4,429 | €4,186 | -€243 | -5.5% |
| Trade debts | 44 | €150,433 | €125,901 | -€24,532 | -16.3% |
| Suppliers | 440/4 | €105,667 | €125,901 | +€20,234 | +19.1% |
| Bills of exchange payable | 441 | €44,766 | - | -€44,766 | |
| Advances received on contracts in progress | 46 | €141 | - | -€141 | |
| Taxes, remuneration and social security | 45 | €63,275 | €26,862 | -€36,413 | -57.5% |
| Taxes | 450/3 | €49,126 | - | -€49,126 | |
| Remuneration and social security | 454/9 | €14,148 | €26,862 | +€12,714 | +89.9% |
| Other amounts payable | 47/48 | €74,675 | - | -€74,675 | |
| Accrued charges and deferred income | 492/3 | €146 | €5,693 | +€5,547 | +3,801% |
| Remuneration, social security and pensions | 62 | €130,640 | €180,120 | +€49,479 | +37.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €26,039 | €46,168 | +€20,129 | +77.3% |
| Other operating charges | 640/8 | €12,305 | €718 | -€11,587 | -94.2% |
| Non-recurring operating charges | 66A | €256 | - | -€256 | |
| Gross operating margin | 9900 | €433,491 | €363,444 | -€70,047 | -16.2% |
| Operating profit (loss) | 9901 | €264,251 | €136,438 | -€127,813 | -48.4% |
| Financial income | 75/76B | €620 | €2 | -€618 | -99.7% |
| Recurring financial income | 75 | €620 | €2 | -€618 | -99.7% |
| Financial charges | 65/66B | €83,470 | €123,545 | +€40,075 | +48.0% |
| Recurring financial charges | 65 | €83,470 | €123,545 | +€40,075 | +48.0% |
| Profit (loss) for the period before taxes | 9903 | €181,400 | €12,895 | -€168,506 | -92.9% |
| Income taxes | 67/77 | €61,468 | €5,381 | -€56,087 | -91.2% |
| Profit (loss) for the period | 9904 | €119,933 | €7,514 | -€112,419 | -93.7% |
| Profit (loss) for the period to be appropriated | 9905 | €119,933 | €7,514 | -€112,419 | -93.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.